Magnetic hyperthermia with ε-Fe(2)O(3) nanoparticles

Biocompatibility restrictions have limited the use of magnetic nanoparticles for magnetic hyperthermia therapy to iron oxides, namely magnetite (Fe(3)O(4)) and maghemite (γ-Fe(2)O(3)). However, there is yet another magnetic iron oxide phase that has not been considered so far, in spite of its unique...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yuanyu, Yoshikiyo, Marie, Namai, Asuka, Bonvin, Debora, Martinez, Abelardo, Piñol, Rafael, Téllez, Pedro, Silva, Nuno J. O., Ahrentorp, Fredrik, Johansson, Christer, Marco-Brualla, Joaquín, Moreno-Loshuertos, Raquel, Fernández-Silva, Patricio, Cui, Yuwen, Ohkoshi, Shin-ichi, Millán, Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055867/
https://www.ncbi.nlm.nih.gov/pubmed/35520081
http://dx.doi.org/10.1039/d0ra04361c

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055867/
https://www.ncbi.nlm.nih.gov/pubmed/35520081
http://dx.doi.org/10.1039/d0ra04361c

Ejemplares similares